Ok, so things are now moving. Looks like its all a matter of process now.Would be great to see it reflected in the share price but that's something we cant control.Bring on March 2020.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%